- Home
- AMRN vs SOR Comparison
AMRN vs SOR Comparison
Compare AMRN & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$13.71
Company Overview
Basic Information| Metric | AMRN | SOR |
|---|---|---|
| Founded | 1989 | 1968 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 391.2M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMRN | SOR |
|---|---|---|
| Price | $13.71 | $46.41 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 94.8K | 16.2K |
| Earning Date | 10-29-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 6.50 |
| Revenue | ★ $226,733,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.08 | $36.41 |
| 52 Week High | $20.90 | $42.75 |
Technical Indicators
Market Signals| Indicator | AMRN | SOR |
|---|---|---|
| Relative Strength Index (RSI) | 39.25 | 46.53 |
| Support Level | $13.48 | $45.61 |
| Resistance Level | $14.49 | $47.75 |
| Average True Range (ATR) | 0.64 | 0.88 |
| MACD | 0.06 | -0.13 |
| Stochastic Oscillator | 24.66 | 33.35 |
Price Performance
Historical Comparison AMRN
SOR
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.